Compare VCEL & TTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VCEL | TTI |
|---|---|---|
| Founded | 1989 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | 1996 | 1996 |
| Metric | VCEL | TTI |
|---|---|---|
| Price | $33.74 | $8.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $58.50 | $10.40 |
| AVG Volume (30 Days) | 718.0K | ★ 1.3M |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.00 | N/A |
| EPS | ★ 0.32 | 0.02 |
| Revenue | ★ $276,259,000.00 | N/A |
| Revenue This Year | $19.10 | $4.38 |
| Revenue Next Year | $17.95 | $11.97 |
| P/E Ratio | ★ $106.66 | $436.00 |
| Revenue Growth | ★ 16.45 | N/A |
| 52 Week Low | $28.95 | $2.03 |
| 52 Week High | $45.97 | $12.54 |
| Indicator | VCEL | TTI |
|---|---|---|
| Relative Strength Index (RSI) | 54.54 | 49.40 |
| Support Level | $30.41 | $6.88 |
| Resistance Level | $34.34 | $8.88 |
| Average True Range (ATR) | 1.76 | 0.46 |
| MACD | 0.29 | 0.14 |
| Stochastic Oscillator | 83.11 | 90.30 |
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
Tetra Technologies Inc is a diversified oil and gas services company, focused on completion fluids and associated products and services, water management, frac flowback, production well testing, offshore rig cooling, and compression services. It has two reporting segments namely Completion Fluids & Products, and Water & Flowback Services. The Completion Fluids & Products Division manufactures and markets clear brine fluids, additives, and associated products and services. Majority of revenue is from Completion Fluids & Products. The company derives maximum revenue from United states.